Blogs about: Non Small Cell Lung Cancer
Featured Blog
Lung Cancer Study of Novel Oral Drug Sapacitabine at CORT
CORT has opened a phase I-II study of sapacitabine for second-line therapy of unresectable advanced or metastatic non-small cell lung cancer (NSCLC). Sapacitabine is an oral nucleoside analog prodrug … more →
Center for Oncology Research & Treatment--Dallas, TX
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report - Aarkstore Enterprise
wrote 6 months ago: Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report con … more →
First Father's Day without Dad
wrote 6 months ago: This photo was taken over 20 Father’s Days ago. Photos and a few old home videos are now the … more →
Gene copy number proving strong indicator of cancer prognosis
wrote 10 months ago: New reports this month highlight the growing importance of gene copy number, as opposed to gene expr … more →
Lung Cancer Study of Novel Oral Drug Sapacitabine at CORT
— 1 comment
wrote 11 months ago: CORT has opened a phase I-II study of sapacitabine for second-line therapy of unresectable advanced … more →
Rare Cancer Presentations: Intraspinal Metastasis of Lung Cancer
— 1 comment
wrote 12 months ago: Author: Barry C. Mirtsching, MD (Center for Oncology Research & Treatment, PA, Dallas, TX) Spin … more →
CORT Study Tests Addition of Avastin (Bevacizumab) in Adjuvant Therapy for Non-Small Cell Lung Cancer
— 1 comment
wrote 1 year ago: Post-operative chemotherapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) has become standard … more →
Tarceva Reaches Phase III Primary Endpoint
wrote 1 year ago: A press release yesterday from Genentech (DNA) reports that its drug Tarceva (erlotinib) reached its … more →
Advances in First-Line Treatment of Unresectable Non-Small Cell Lung Cancer: Pemetrexed Maintenance Therapy
— 1 comment
wrote 1 year ago: Chemotherapy is the initial standard-of-care treatment for unresectable (stage IIIB/IV) non-small ce … more →
Stimuvax Lung Cancer Vaccine Study Continues at CORT
— 1 comment
wrote 1 year ago: CORT opened and enrolled in 2007 the first patient worldwide to the START Study (Stimulating Targete … more →
Seliciclib (CYC-202) in Treatment of Refractory Non-Small Cell Lung Cancer
wrote 2 years ago: CYC-202 is a cyclin-dependent kinase (CDK) inhibitor. CDK proteins regulate the process of cell divi … more →
Lung Cancer Survival Improved by Cetuximab (Erbitux)
wrote 2 years ago: ImClone and Bristol Myers Squibb (BMS) released a press announcement on 9/12/07 that cetuximab (Erbi … more →
